Report Detail

Other Global Orthobiologics Market Insights, Forecast to 2025

  • RnM2328032
  • |
  • 17 June, 2019
  • |
  • Global
  • |
  • 120 Pages
  • |
  • QYResearch
  • |
  • Other

Orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in your body.
The rising geriatric population can be considered as a beneficial prospect. Increasing geriatric population offers surplus opportunities for the manufactures of orthobiologics. The major root of amputations are diseases related to ageing as osteoarthritis, musculoskeletal diseases, spine deformity, etc. Increase incidence of accidents owing to increasing urbanization is also a major factor expected to create numerous opportunities for orthobiologics manufacturers. Elevating surgical procedures also presents growth opportunities for the market. The increased incidences of trauma cases, lifestyle related diseases and other chronic disorders have led to rise in number of orthopaedic surgeries at a global level. This growing trend is anticipated to increase the sales of orthobiologics products in present and forthcoming years.

The global Orthobiologics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orthobiologics market based on company, product type, end user and key regions.

This report studies the global market size of Orthobiologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Orthobiologics in these regions.
This research report categorizes the global Orthobiologics market by top players/brands, region, type and end user. This report also studies the global Orthobiologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
NuVasive
Stryker
Zimmer
Orthofix
Anika Therapeutics
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex
SeaSpine
Sanofi-Aventis (Sanofi)
Djo Global
Seikagaku
RTI Surgical
Heraeus
Fidia Pharma
TRB
Allosource
Musculoskeletal Transplant Foundation
Ito

Market size by Product
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
Market size by End User
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Orthobiologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Orthobiologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Orthobiologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Orthobiologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Orthobiologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orthobiologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Orthobiologics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Orthobiologics Market Size Growth Rate by Product
      • 1.4.2 Bone Growth Stimulators (BGS)
      • 1.4.3 Viscosupplements
      • 1.4.4 Bone Graft Substitute
    • 1.5 Market by End User
      • 1.5.1 Global Orthobiologics Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centres
      • 1.5.4 Orthopaedics Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Orthobiologics Market Size
      • 2.1.1 Global Orthobiologics Revenue 2014-2025
      • 2.1.2 Global Orthobiologics Sales 2014-2025
    • 2.2 Orthobiologics Growth Rate by Regions
      • 2.2.1 Global Orthobiologics Sales by Regions
      • 2.2.2 Global Orthobiologics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Orthobiologics Sales by Manufacturers
      • 3.1.1 Orthobiologics Sales by Manufacturers
      • 3.1.2 Orthobiologics Sales Market Share by Manufacturers
      • 3.1.3 Global Orthobiologics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Orthobiologics Revenue by Manufacturers
      • 3.2.1 Orthobiologics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Orthobiologics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Orthobiologics Price by Manufacturers
    • 3.4 Orthobiologics Manufacturing Base Distribution, Product Types
      • 3.4.1 Orthobiologics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Orthobiologics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Orthobiologics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Orthobiologics Sales by Product
    • 4.2 Global Orthobiologics Revenue by Product
    • 4.3 Orthobiologics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Orthobiologics Breakdown Data by End User

    6 North America

    • 6.1 North America Orthobiologics by Countries
      • 6.1.1 North America Orthobiologics Sales by Countries
      • 6.1.2 North America Orthobiologics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Orthobiologics by Product
    • 6.3 North America Orthobiologics by End User

    7 Europe

    • 7.1 Europe Orthobiologics by Countries
      • 7.1.1 Europe Orthobiologics Sales by Countries
      • 7.1.2 Europe Orthobiologics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Orthobiologics by Product
    • 7.3 Europe Orthobiologics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Orthobiologics by Countries
      • 8.1.1 Asia Pacific Orthobiologics Sales by Countries
      • 8.1.2 Asia Pacific Orthobiologics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Orthobiologics by Product
    • 8.3 Asia Pacific Orthobiologics by End User

    9 Central & South America

    • 9.1 Central & South America Orthobiologics by Countries
      • 9.1.1 Central & South America Orthobiologics Sales by Countries
      • 9.1.2 Central & South America Orthobiologics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Orthobiologics by Product
    • 9.3 Central & South America Orthobiologics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Orthobiologics by Countries
      • 10.1.1 Middle East and Africa Orthobiologics Sales by Countries
      • 10.1.2 Middle East and Africa Orthobiologics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Orthobiologics by Product
    • 10.3 Middle East and Africa Orthobiologics by End User

    11 Company Profiles

    • 11.1 Medtronic
      • 11.1.1 Medtronic Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Medtronic Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Medtronic Orthobiologics Products Offered
      • 11.1.5 Medtronic Recent Development
    • 11.2 NuVasive
      • 11.2.1 NuVasive Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 NuVasive Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 NuVasive Orthobiologics Products Offered
      • 11.2.5 NuVasive Recent Development
    • 11.3 Stryker
      • 11.3.1 Stryker Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Stryker Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Stryker Orthobiologics Products Offered
      • 11.3.5 Stryker Recent Development
    • 11.4 Zimmer
      • 11.4.1 Zimmer Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Zimmer Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Zimmer Orthobiologics Products Offered
      • 11.4.5 Zimmer Recent Development
    • 11.5 Orthofix
      • 11.5.1 Orthofix Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Orthofix Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Orthofix Orthobiologics Products Offered
      • 11.5.5 Orthofix Recent Development
    • 11.6 Anika Therapeutics
      • 11.6.1 Anika Therapeutics Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Anika Therapeutics Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Anika Therapeutics Orthobiologics Products Offered
      • 11.6.5 Anika Therapeutics Recent Development
    • 11.7 DePuy Synthes (Johnson & Johnson)
      • 11.7.1 DePuy Synthes (Johnson & Johnson) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Products Offered
      • 11.7.5 DePuy Synthes (Johnson & Johnson) Recent Development
    • 11.8 Bioventus
      • 11.8.1 Bioventus Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bioventus Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bioventus Orthobiologics Products Offered
      • 11.8.5 Bioventus Recent Development
    • 11.9 Arthrex
      • 11.9.1 Arthrex Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Arthrex Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Arthrex Orthobiologics Products Offered
      • 11.9.5 Arthrex Recent Development
    • 11.10 SeaSpine
      • 11.10.1 SeaSpine Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 SeaSpine Orthobiologics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 SeaSpine Orthobiologics Products Offered
      • 11.10.5 SeaSpine Recent Development
    • 11.11 Sanofi-Aventis (Sanofi)
    • 11.12 Djo Global
    • 11.13 Seikagaku
    • 11.14 RTI Surgical
    • 11.15 Heraeus
    • 11.16 Fidia Pharma
    • 11.17 TRB
    • 11.18 Allosource
    • 11.19 Musculoskeletal Transplant Foundation
    • 11.20 Ito

    12 Future Forecast

    • 12.1 Orthobiologics Market Forecast by Regions
      • 12.1.1 Global Orthobiologics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Orthobiologics Revenue Forecast by Regions 2019-2025
    • 12.2 Orthobiologics Market Forecast by Product
      • 12.2.1 Global Orthobiologics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Orthobiologics Revenue Forecast by Product 2019-2025
    • 12.3 Orthobiologics Market Forecast by End User
    • 12.4 North America Orthobiologics Forecast
    • 12.5 Europe Orthobiologics Forecast
    • 12.6 Asia Pacific Orthobiologics Forecast
    • 12.7 Central & South America Orthobiologics Forecast
    • 12.8 Middle East and Africa Orthobiologics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Orthobiologics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Orthobiologics. Industry analysis & Market Report on Orthobiologics is a syndicated market report, published as Global Orthobiologics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Orthobiologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,910.20
      5,865.30
      7,820.40
      4,576.60
      6,864.90
      9,153.20
      765,723.00
      1,148,584.50
      1,531,446.00
      409,101.00
      613,651.50
      818,202.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report